Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.34 BRL | +18.14% |
|
-0.06% | +52.62% |
Jun. 14 | Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy | RE |
Jun. 14 | Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup | DJ |
Sales 2024 * | 291B 41.8B 225B | Sales 2025 * | 352B 50.49B 272B | Capitalization | 4,396B 631B 3,392B |
---|---|---|---|---|---|
Net income 2024 * | 105B 15.02B 80.81B | Net income 2025 * | 128B 18.33B 98.59B | EV / Sales 2024 * | 15.2 x |
Net Debt 2024 * | 22.09B 3.17B 17.04B | Net cash position 2025 * | 6.04B 866M 4.66B | EV / Sales 2025 * | 12.5 x |
P/E ratio 2024 * |
42.4
x | P/E ratio 2025 * |
34.5
x | Employees | 66,015 |
Yield 2024 * |
1.2% | Yield 2025 * |
1.47% | Free-Float | 70.17% |
Latest transcript on Novo Nordisk A/S
1 day | +18.14% | ||
1 week | -0.06% | ||
Current month | +5.93% | ||
1 month | +10.22% | ||
3 months | +15.21% | ||
6 months | +58.71% | ||
Current year | +52.62% |
![Extreme 91](/images/extremecours_fleche.png)
![Extreme 83](/images/extremecours_fleche.png)
![Extreme 61.74](/images/extremecours_fleche.png)
![Extreme 45.59](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
![Extreme 30.55](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 90-12-31 | |
Director of Finance/CFO | 53 | 98-12-31 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 62 | 15-03-18 |
Helge Lund
CHM | Chairman | 61 | 17-03-22 |
Martin MacKay
BRD | Director/Board Member | 68 | 18-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 95.34 | -0.49% | 17,140 |
24-06-13 | 95.81 | -1.24% | 4,730 |
24-06-12 | 97.01 | +1.89% | 15,283 |
24-06-11 | 95.21 | -1.20% | 2,527 |
24-06-10 | 96.37 | +1.02% | 2,978 |
Delayed Quote Sao Paulo, June 14, 2024 at 04:11 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- NOVO B Stock
- N1VO34 Stock